Osteoporosis International

, Volume 29, Issue 2, pp 365–373 | Cite as

Older men who sustain a hip fracture experience greater declines in bone mineral density at the contralateral hip than non-fractured comparators

  • A. M. RathbunEmail author
  • J. Magaziner
  • M. D. Shardell
  • L. M. Yerges-Armstrong
  • D. Orwig
  • G. E. Hicks
  • M. C. Hochberg
Original Article



Men experience declining bone mineral density (BMD) after hip fracture; however, changes attributable to fracture are unknown. This study evaluated the excess BMD decline attributable to hip fracture among older men. Older men with hip fracture experienced accelerated BMD declines and are at an increased risk of secondary fractures.


The objective was to determine whether bone mineral density (BMD) changes in men after hip fracture exceed that expected with aging.


Two cohorts were used: Baltimore Hip Studies 7th cohort (BHS-7) and Baltimore Men’s Osteoporosis Study (MOST). BHS-7 recruited older adults (N = 339) hospitalized for hip fracture; assessments occurred within 22 days of admission and at 2, 6, and 12 months follow-up. MOST enrolled age-eligible men (N = 694) from population-based listings; data were collected at a baseline visit and a second visit that occurred between 10 and 31 months later. The combined sample (n = 452) consisted of Caucasian men from BHS-7 (n = 89) and MOST (n = 363) with ≥ 2 dual-energy X-ray absorptiometry scans and overlapping ranges of age, height, and weight. Mixed-effect models estimated rates of BMD change, and generalized linear models evaluated differences in annual bone loss at the total hip and femoral neck between cohorts.


Adjusted changes in total hip and femoral neck BMD were − 4.16% (95% CI, − 4.87 to − 3.46%) and − 4.90% (95% CI, − 5.88 to − 3.92%) in BHS-7 participants; − 1.57% (95% CI, − 2.19 to − 0.96%) and − 0.99% (95% CI, − 1.88 to − 0.10%) in MOST participants; and statistically significant (P < 0.001) between-group differences in change were − 2.59% (95% CI, − 3.26 to − 1.91%) and − 3.91% (95% CI, − 4.83 to − 2.98%), respectively.


Hip fracture in older men is associated with accelerated BMD declines at the non-fractured hip that are greater than those expected during aging, and pharmacological interventions in this population to prevent secondary fractures may be warranted.


Aging Epidemiology Fracture prevention Hip fracture Osteoporosis 



This material is based on upon work supported (or supported in part) by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, VA Maryland Health Care System, and Baltimore VA Medical Center. The authors would like to thank the facilities, orthopedic surgeons, and hospital personnel; Baltimore Hip Studies research staff; and participants for volunteering their time and information for this work.


This work was supported by grants from the National Institute on Aging (R37 AG009901, R01 AG029315, P30 AG028747, and T32 AG000262). The funding sponsor had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the article for publication.

Compliance with ethical standards

Conflict of interest

Jay Magaziner has consulting agreements with Ammonett, Novartis, and Pluristem. Denise Orwig has consulting agreements with Viking Therapeutics, Inc. Laura M. Yerges-Armstrong is a statistical geneticist at GlaxoSmithKline. Drs. Alan M. Rathbun, Michelle D. Shardell, Gregory E. Hicks, and Marc C. Hochberg have no disclosures to declare.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individuals participants included in the study.

Supplementary material

198_2017_4280_MOESM1_ESM.docx (22 kb)
Supplemental Table 1 (DOCX 22 kb)
198_2017_4280_MOESM2_ESM.docx (22 kb)
Supplemental Table 2 (DOCX 22 kb)
198_2017_4280_MOESM3_ESM.docx (22 kb)
Supplemental Table 3 (DOCX 21 kb)
198_2017_4280_MOESM4_ESM.docx (22 kb)
Supplemental Table 4 (DOCX 21 kb)


  1. 1.
    Beck TJ, Ruff CB, Scott WW Jr, Plato CC, Tobin JD, Quan CA (1992) Sex differences in geometry of the femoral neck with aging: a structural analysis of bone mineral data. Calcif Tissue Int 50(1):24–29CrossRefGoogle Scholar
  2. 2.
    Seeman E (2002) Pathogenesis of bone fragility in women and men. Lancet 359(9320):1841–1850CrossRefGoogle Scholar
  3. 3.
    Lambert JK, Zaidi M, Mechanick JI (2011) Male osteoporosis: epidemiology and the pathogenesis of aging bones. Curr Osteoporos Rep 9(4):229–236CrossRefGoogle Scholar
  4. 4.
    Melton L (1993) Hip fractures: a worldwide problem today and tomorrow. Bone 14:1–8CrossRefGoogle Scholar
  5. 5.
    Curtis EM, Moon RJ, Harvey NC, Cooper C (2017) The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide. BoneGoogle Scholar
  6. 6.
    Stevens JA, Rudd RA (2013) The impact of decreasing US hip fracture rates on future hip fracture estimates. Osteoporos Int 24(10):2725–2728CrossRefGoogle Scholar
  7. 7.
    Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P et al (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20(7):1185–1194CrossRefGoogle Scholar
  8. 8.
    Beck TJ, Looker AC, Ruff CB, Sievanen H, Wahner HW (2000) Structural trends in the aging femoral neck and proximal shaft: analysis of the Third National Health and Nutrition Examination Survey dual-energy X-ray absorptiometry data. J Bone Miner Res 15(12):2297–2304CrossRefGoogle Scholar
  9. 9.
    Cawthon PM, Ewing SK, Mackey DC, Fink HA, Cummings SR, Ensrud KE et al (2012) Change in hip bone mineral density and risk of subsequent fractures in older men. J Bone Miner Res 27(10):2179–2188CrossRefGoogle Scholar
  10. 10.
    Cawthon PM, Ewing SK, McCulloch CE, Ensrud KE, Cauley JA, Cummings SR et al (2009) Loss of hip BMD in older men: the osteoporotic fractures in men (MrOS) study. J Bone Miner Res 24(10):1728–1735CrossRefGoogle Scholar
  11. 11.
    Esenyel M, Ozen A, Esenyel CZ, Rezvani A, Sariyildiz MA, Ergin O (2011) Hip structural changes and fracture risk in osteopenia and osteoporosis. Eurasian J Med 43(2):73CrossRefGoogle Scholar
  12. 12.
    Yates LB, Karasik D, Beck TJ, Cupples LA, Kiel DP (2007) Hip structural geometry in old and old-old age: similarities and differences between men and women. Bone 41(4):722–732CrossRefGoogle Scholar
  13. 13.
    Colón-Emeric C, Kuchibhatla M, Pieper C, Hawkes W, Fredman L, Magaziner J et al (2003) The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteoporos Int 14(11):879–883CrossRefGoogle Scholar
  14. 14.
    Rathbun AM, Shardell M, Orwig D, Hebel JR, Hicks GE, Beck T et al (2016) Differences in the trajectory of bone mineral density change measured at the total hip and femoral neck between men and women following hip fracture. Arch Osteoporos 11(1):1–9CrossRefGoogle Scholar
  15. 15.
    Rathbun AM, Shardell M, Orwig D, Hebel JR, Hicks GE, Beck TJ et al (2016) Difference in the trajectory of change in bone geometry as measured by hip structural analysis in the narrow neck, intertrochanteric region, and femoral shaft between men and women following hip fracture. Bone 92:124–131CrossRefGoogle Scholar
  16. 16.
    Tracy JK, Meyer WA, Flores RH, Wilson PD, Hochberg MC (2005) Racial differences in rate of decline in bone mass in older men: the Baltimore men’s osteoporosis study. J Bone Miner Res 20(7):1228–1234CrossRefGoogle Scholar
  17. 17.
    Orwoll E, Blank JB, Barrett-Connor E, Cauley J, Cummings S, Ensrud K et al (2005) Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study—a large observational study of the determinants of fracture in older men. Contemp Clin Trials 26(5):569–585CrossRefGoogle Scholar
  18. 18.
    Shardell M, Hicks GE, Ferrucci L (2015) Doubly robust estimation and causal inference in longitudinal studies with dropout and truncation by death. Biostatistics (Oxford, England) 16(1):155–168CrossRefGoogle Scholar
  19. 19.
    Shardell M, Hicks GE, Miller RR, Magaziner J (2010) Semiparametric regression models for repeated measures of mortal cohorts with non-monotone missing outcomes and time-dependent covariates. Stat Med 29(22):2282–2296CrossRefGoogle Scholar
  20. 20.
    Bliese P. (2006) Multilevel modeling in R (2.2)—a brief introduction to R, the multilevel package and the nlme packageGoogle Scholar
  21. 21.
    Magaziner J, Wehren L, Hawkes WG, Orwig D, Hebel JR, Fredman L et al (2006) Women with hip fracture have a greater rate of decline in bone mineral density than expected: another significant consequence of a common geriatric problem. Osteoporos Int 17(7):971–977CrossRefGoogle Scholar
  22. 22.
    Reider L, Beck TJ, Hochberg MC, Hawkes WG, Orwig D, YuYahiro JA et al (2010) Women with hip fracture experience greater loss of geometric strength in the contralateral hip during the year following fracture than age-matched controls. Osteoporos Int 21(5):741–750CrossRefGoogle Scholar
  23. 23.
    Benjamini Y, Hochberg Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Ser B (Methodological) 289–300Google Scholar
  24. 24.
    Orwig DL, Chan J, Magaziner J (2006) Hip fracture and its consequences: differences between men and women. Orthop Clin N Am 37(4):611–622CrossRefGoogle Scholar
  25. 25.
    Magaziner J, Fredman L, Hawkes W, Hebel JR, Zimmerman S, Orwig DL et al (2003) Changes in functional status attributable to hip fracture: a comparison of hip fracture patients to community-dwelling aged. Am J Epidemiol 157(11):1023–1031CrossRefGoogle Scholar
  26. 26.
    Magaziner J, Lydick E, Hawkes W, Fox KM, Zimmerman SI, Epstein RS et al (1997) Excess mortality attributable to hip fracture in white women aged 70 years and older. Am J Public Health 87(10):1630–1636CrossRefGoogle Scholar
  27. 27.
    Hansen MA, Overgaard K, Christiansen C (1995) Spontaneous postmenopausal bone loss in different skeletal areas—followed up for 15 years. J Bone Miner Res 10(2):205–210CrossRefGoogle Scholar
  28. 28.
    Ensrud KE, Palermo L, Black DM, Cauley J, Jergas M, Orwoll ES et al (1995) Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res 10(11):1778–1787CrossRefGoogle Scholar
  29. 29.
    Hansen MA, Overgaard K, Riis BJ, Christiansen C (1991) Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ 303(6808):961–964CrossRefGoogle Scholar
  30. 30.
    Szulc P, Seeman E, Duboeuf F, Sornay-Rendu E, Delmas PD (2006) Bone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women. J Bone Miner Res 21(12):1856–1863CrossRefGoogle Scholar
  31. 31.
    Szulc P, Delmas PD (2007) Bone loss in elderly men: increased endosteal bone loss and stable periosteal apposition. The prospective MINOS study. Osteoporos Int 18(4):495–503CrossRefGoogle Scholar
  32. 32.
    Fox KM, Magaziner J, Hawkes WG, Yu-Yahiro J, Hebel JR, Zimmerman SI et al (2000) Loss of bone density and lean body mass after hip fracture. Osteoporos Int 11(1):31–35CrossRefGoogle Scholar
  33. 33.
    Wehren LE, Hawkes WG, Hebel JR, Orwig D, Zimmerman SI, Fox KM et al (2004) Predictors of bone loss after hip fracture. Osteoporos Int 15(2):125–131CrossRefGoogle Scholar
  34. 34.
    Boonen S, Orwoll E, Magaziner J, Colón-Emeric CS, Adachi JD, Bucci-Rechtweg C et al (2011) Once-yearly zoledronic acid in older men compared with women with recent hip fracture. J Am Geriatr Soc 59(11):2084–2090CrossRefGoogle Scholar
  35. 35.
    Antonelli M, Einstadter D, Magrey M (2014) Screening and treatment of osteoporosis after hip fracture: comparison of sex and race. J Clin Densitom 17(4):479–483CrossRefGoogle Scholar
  36. 36.
    Groenwold RHH, Sterne JAC, Lawlor DA, Moons KGM, Hoes AW, Tilling K (2016) Sensitivity analysis for the effects of multiple unmeasured confounders. Ann Epidemiol 26(9):605–611CrossRefGoogle Scholar
  37. 37.
    Wehren LE, Hawkes WG, Hebel JR, Orwig DL, Magaziner J (2005) Bone mineral density, soft tissue body composition, strength, and functioning after hip fracture. J Gerontol A Biol Sci Med Sci 60(1):80–84CrossRefGoogle Scholar
  38. 38.
    Beaupre LA, Binder EF, Cameron ID, Jones CA, Orwig D, Sherrington C et al (2013) Maximising functional recovery following hip fracture in frail seniors. Best Pract Res Clin Rheumatol 27(6):771–788CrossRefGoogle Scholar
  39. 39.
    Magaziner JS, Orwig DL, Lyles KW, Nordsletten L, Boonen S, Adachi JD et al (2014) Subgroup variations in bone mineral density response to zoledronic acid after hip fracture. J Bone Miner Res 29(12):2545–2551CrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2017

Authors and Affiliations

  • A. M. Rathbun
    • 1
    • 2
    Email author
  • J. Magaziner
    • 2
  • M. D. Shardell
    • 3
  • L. M. Yerges-Armstrong
    • 4
  • D. Orwig
    • 2
  • G. E. Hicks
    • 5
  • M. C. Hochberg
    • 2
  1. 1.Geriatric Research Education and Clinical CenterVA Maryland Health Care SystemBaltimoreUSA
  2. 2.Department of Epidemiology and Public HealthUniversity of Maryland School of MedicineBaltimoreUSA
  3. 3.Translational Gerontology BranchNational Institutes on AgingBaltimoreUSA
  4. 4.Target Sciences Research and DevelopmentGlaxoSmithKlineKing of PrussiaUSA
  5. 5.Department of Physical TherapyUniversity of DelawareNewarkUSA

Personalised recommendations